Trial intelligence / Profile preview

Relative Bioavailability of Zoloft Oral Solution vs Tablets in Healthy Subjects

NCT03711708Phase 4Completed

Sponsor
Viatris
Start
Nov 2018
Primary completion
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of sertraline in major depressive disorder (MDD), obsessive compulsive disorder (OCD), panic disorder and 3 more (2 arms), sponsored by Viatris. Primary endpoints: Area under the sertraline plasma concentration-time curve from time zero to last time point and Maximum observed plasma concentration of sertraline. Started Nov 2018; status: completed.

02

Drugs

sertraline
03

Conditions

major depressive disorder (MDD)obsessive compulsive disorder (OCD)panic disorderpost-traumatic stress disorder (PTSD)Social Anxiety Disorder (SAD)

Beyond the preview

Go deeper on NCT03711708.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03711708.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call